Loading...
Derniers dépôts
-
Simon Décary, Maarten de Wit, Florian Naye, Jennifer Barton, Liana Fraenkel, et al.. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials. Seminars in Arthritis and Rheumatism, 2024, 65, pp.152381. ⟨10.1016/j.semarthrit.2024.152381⟩. ⟨hal-04564112⟩
-
Philip Mease, Arthur Kavanaugh, Dafna Gladman, Oliver Fitzgerald, Enrique R. Soriano, et al.. Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials. Rheumatology and Therapy, 2022, 9 (4), pp.1181--1191. ⟨10.1007/s40744-022-00449-6⟩. ⟨hal-03896058⟩
-
Laure Gossec, Pierre Chauvin, Alain Saraux, Christophe Hudry, Gabrielle Cukierman, et al.. Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis : the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire. Annals of the Rheumatic Diseases, 2018, 77 (2), pp.258 - 263. ⟨10.1136/annrheumdis-2017-212000⟩. ⟨hal-01795691⟩
-
Xenofon Baraliakos, Effie Pournara, Laure Gossec, Philip J Mease, Roisin White, et al.. Predictors of Response to Secukinumab in Patients with Psoriatic Arthritis and Axial Manifestations: A Post-Hoc Analysis of the MAXIMISE Trial. RMD Open : Rheumatic & Musculoskeletal Diseases, 2022, 8 (2), pp.e002303. ⟨10.1136/rmdopen-2022-002303⟩. ⟨hal-03892129⟩
-
Saskia Lawson-Tovey, Kimme Hyrich, Laure Gossec, Anja Strangfeld, Loreto Carmona, et al.. SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases, 2022, 81 (1), pp.145-150. ⟨10.1136/annrheumdis-2021-221217⟩. ⟨hal-03744697⟩
-
Laure Gossec, Francis Berenbaum, Pierre Chauvin, Christophe Hudry, Gabrielle Cukierman, et al.. Correction to: Development and Application of a Questionnaire to Assess Patient Beliefs in Rheumatoid Arthritis and Axial Spondyloarthritis. Clinical Rheumatology, 2018, 37 (10), pp.2659--2659. ⟨10.1007/s10067-018-4241-9⟩. ⟨hal-03888124⟩
-
Andreas Kerschbaumer, Josef S Smolen, Maxime Dougados, Maarten De Wit, Jette Primdahl, et al.. Pharmacological Treatment of Psoriatic Arthritis: A Systematic Literature Research for the 2019 Update of the EULAR Recommendations for the Management of Psoriatic Arthritis. Annals of the Rheumatic Diseases, 2020, 79 (6), pp.778--786. ⟨10.1136/annrheumdis-2020-217163⟩. ⟨hal-03894171⟩
-
Florian Lucasson, Uta Kiltz, Umut Kalyoncu, Ying Ying Leung, Penelope Palominos, et al.. Disparities in Healthcare in Psoriatic Arthritis: An Analysis of 439 Patients from 13 Countries. RMD Open : Rheumatic & Musculoskeletal Diseases, 2022, 8 (1), pp.e002031. ⟨10.1136/rmdopen-2021-002031⟩. ⟨hal-03896044⟩
-
Jean Liew, Milena Gianfrancesco, Carly Harrison, Zara Izadi, Stephanie Rush, et al.. SARS-CoV-2 Breakthrough Infections among Vaccinated Individuals with Rheumatic Disease: Results from the COVID-19 Global Rheumatology Alliance Provider Registry. RMD Open : Rheumatic & Musculoskeletal Diseases, 2022, 8 (1), pp.e002187. ⟨10.1136/rmdopen-2021-002187⟩. ⟨hal-03896038⟩
-
Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, Loreto Carmona, Maria I Danila, et al.. Characteristics Associated with Hospitalisation for COVID-19 in People with Rheumatic Disease: Data from the COVID-19 Global Rheumatology Alliance Physician-Reported Registry. Annals of the Rheumatic Diseases, 2020, 79 (7), pp.859--866. ⟨10.1136/annrheumdis-2020-217871⟩. ⟨hal-03849959⟩
-
Ying Ying Leung, Ana-Maria Orbai, Maarten Wit, Andra Balanescu, Emmanuelle Dernis, et al.. Comparing the Patient-Reported Physical Function Outcome Measures in a Real-Life International Cohort of Patients With Psoriatic Arthritis. Arthritis Care & Research = Arthritis Care and Research, 2021, 73 (4), pp.593--602. ⟨10.1002/acr.24139⟩. ⟨hal-03896035⟩
-
Ana-Maria Orbai, Jamie Perin, Clémence Gorlier, Laura C. Coates, Uta Kiltz, et al.. Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association WithSex in 458 Patients From Fourteen Countries. Arthritis Care & Research = Arthritis Care and Research, 2020, 72 (12), pp.1772--1779. ⟨10.1002/acr.24090⟩. ⟨hal-03879080⟩
-
Nelly Ziadé, Noura Abbas, Ihsane Hmamouchi, Lina El Kibbi, Avin Maroof, et al.. Is the patient-perceived impact of psoriatic arthritis a global concept? An international study in 13 Arab countries (TACTIC study). Rheumatology International, 2024, 44 (5), pp.885-899. ⟨10.1007/s00296-024-05552-1⟩. ⟨hal-04564231⟩
-
Laetitia Marson, Sabrina Dadoun, Fanny Roure, Sylvie Rozenberg, Marc Marty, et al.. Entering Functional Restoration Programs for Chronic Low Back Pain is Delayed when Patients do not Receive Support at Work: a study of 185 patients in France. The Lancet, In press, ⟨10.1016/j.jbspin.2024.105721⟩. ⟨hal-04564167⟩
-
Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, et al.. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the Rheumatic Diseases, 2024, pp.ard-2024-225531. ⟨10.1136/ard-2024-225531⟩. ⟨hal-04564234⟩
-
Laura C Coates, Robert Landewé, Iain B Mcinnes, Philip J Mease, Christopher T Ritchlin, et al.. Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD Open, 2024, 10 (1), pp.e003855. ⟨10.1136/rmdopen-2023-003855⟩. ⟨hal-04564137⟩
-
Laure Gossec, Brittany Humphries, Megan Rutherford, Vanessa Taieb, Damon Willems, et al.. Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis. Arthritis Research & Therapy, 2024, 26, ⟨10.1186/s13075-024-03282-0⟩. ⟨hal-04564135⟩